Downregulation of TAp63 and unaffected levels of p63beta distinguishes oral wounds from SCCHN.
Niklas
N
Thurfjell
Philip J
PJ
Coates
Ylva-Britt
YB
Wahlin
Elin
E
Arvidsson
Karin
K
Nylander
D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000378:metabolism; D004268:DNA-Binding Proteins; D015536:Down-Regulation; D016147:Genes, Tumor Suppressor; D006258:Head and Neck Neoplasms / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D009061:Mouth Mucosa / Q000378:metabolism / Q000473:pathology*; D010750:Phosphoproteins / Q000235:genetics*; D020033:Protein Isoforms / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D015534:Trans-Activators / Q000235:genetics*; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; D014947:Wounds and Injuries / Q000235:genetics* / Q000473:pathology*
D004268:DNA-Binding Proteins; D010750:Phosphoproteins; D020033:Protein Isoforms; D012333:RNA, Messenger; C115051:TP63 protein, human; D015534:Trans-Activators; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins